Src inhibition is still a relevant target in pancreatic cancer

Oncologist. 2014 Feb;19(2):211. doi: 10.1634/theoncologist.2013-0410. Epub 2014 Jan 23.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Humans
  • Neoplasm Metastasis / drug therapy*
  • Pancreatic Neoplasms / drug therapy*
  • Pyrimidines / administration & dosage*
  • Thiazoles / administration & dosage*

Substances

  • Pyrimidines
  • Thiazoles

Associated data

  • ClinicalTrials.gov/NCT01652976